Clinical Trial Update: Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing liposomal bupivacaine (Exparel) for post-mastectomy analgesia against standard bupivacaine or placebo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Mastectomy

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Georgetown University | Conditions: Mastectomy, Breast Cancer | Phase 2 | Status: UNKNOWN